You have 9 free searches left this month | for more free features.

Hematological Malignancies

Showing 51 - 75 of 3,813

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination

Active, not recruiting
  • Pediatric Cancer
  • +2 more
  • Durvalumab / Tremelimumab Combination Therapy
  • Baltimore, Maryland
  • +18 more
Nov 3, 2022

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Biological Samples From Patients Treated With CAR-T Cells for

Recruiting
  • Lymphoma and Acute Lymphoblastic Leukemia
  • additional biological samples during CAR-T CELL treatment
  • Montpellier, France
    Département d'hématologie clinique
Dec 21, 2021

Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)

Recruiting
  • Haematological Malignancy
  • 6 sessions of adapted physical activity after stem cell transplant
  • Nice, France
    CHU NICE, hopital ARCHET 1, hématologie
Jun 13, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Hematological Malignancies Treated With Intensive Chemo Trial in Saint-Étienne (Tranexamic acid)

Recruiting
  • Hematological Malignancies Treated With Intensive Chemotherapy
  • Tranexamic acid
  • Saint-Étienne, France
    CHU de Saint-Etienne
Feb 7, 2022

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

Recruiting
  • Isocitrate Dehydrogenase Gene Mutation
  • Atlanta, Georgia
  • +6 more
Feb 22, 2022

Immunogenicity of Covid-19 Vaccination for Hematological

Active, not recruiting
  • Immunogenicity
  • +3 more
    • Varese, Lombardia, Italy
      UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
    Sep 10, 2021

    Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)

    Suspended
    • Pseudomonas Aeruginosa
    • +2 more
    • Ceftolozane / Tazobactam Injection
    • New York, New York
      Weill Cornell Medicine
    Jan 25, 2022

    Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)

    Recruiting
    • Hematological Malignancies
    • Guangzhou, Guangdong, China
    • +2 more
    Aug 10, 2022

    Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

    Not yet recruiting
    • Hematologic Malignancy
    • +2 more
    • Flow Cytometry
    • Nanjing, Jiangsu, China
    • +2 more
    Apr 17, 2023

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • DSP107
    • +2 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center, Department of
    Nov 13, 2022

    Blood Clots and Bleeding in Hematological Malignancies, HAT

    Recruiting
    • Acute Leukemia
    • +7 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jun 17, 2022

    Tissue Specimens From Solid Tumors or Blood Disorders and Their

    Recruiting
    • Neoplasms
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

      Recruiting
      • Hematological Malignancies
      • Total Body Irradiation
      • +6 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 4, 2022

      Solid Tumor, Hematological Malignancies Trial in Santa Monica (Belinostat, Atazanavir)

      Recruiting
      • Solid Tumor
      • Hematological Malignancies
      • Santa Monica, California
        John Wayne Cancer Institute @ Providence Saint John's Health Cen
      Jan 31, 2023

      Optical Genome Mapping in Hematological Malignancies

      Recruiting
      • MDS
      • +2 more
        • Brest, France
        • +3 more
        Aug 16, 2021

        Hematological Malignancies Trial in Durham (fostamatinib)

        Active, not recruiting
        • Hematological Malignancies
        • Durham, North Carolina
          Duke University of Medicine
        Jul 14, 2022

        Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

        Active, not recruiting
        • Hematological Malignancies
        • Duarte, California
        • +26 more
        Dec 7, 2022

        T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

        Recruiting
        • T-cell Lymphoma
        • T-cell Leukemia
        • CD4CAR
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Dec 16, 2022

        Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • TQB2928 Injection + Azacitidine for injection
        • Beijing, Beijing, China
        • +8 more
        Aug 22, 2023

        Adapted Physical Activity, Hematological Malignancies, Anxiety Trial (Classical APA group:, APA with Exergaming device, APA

        Not yet recruiting
        • Adapted Physical Activity
        • +3 more
        • Classical APA group:
        • +2 more
        • (no location specified)
        Jul 25, 2022

        Hematological Malignancies Trial in Beijing, Tianjin (TQB3820 tablets)

        Recruiting
        • Hematological Malignancies
        • TQB3820 tablets
        • Beijing, Beijing, China
        • +1 more
        Sep 18, 2021

        Advanced Malignant Tumor Trial in Spain, United States (KO-947)

        Terminated
        • Advanced Malignant Neoplasm
        • Rochester, Minnesota
        • +4 more
        Sep 16, 2021